The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs ...
The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. In ...
Metagenomi, Inc. announced positive results from a nonhuman primate study on their hemophilia A therapy, showing sustained factor VIII (FVIII) activity for around 19 months with a favorable safety ...
BOSTON and SUZHOU, China, June 10, 2026 /PRNewswire/ -- HkeyBio, a specialized preclinical CRO focused on autoimmune and allergic disease research, today unveiled its NHP Fast-PoC (Rapid ...
The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results